Boehringer Ingelheim convenes "Detect the SOS" Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks

Boehringer Ingelheim convenes "Detect the SOS" Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks News provided by Boehringer Ingelheim Jan 28, 2026, 08:00 ET Share this article Share to X Share this article Share to X Detect the SOS Collective is comprised of: Boehringer Ingelheim, the American Diabetes Association®, National Kidney Foundation, WomenHeart, and The Mended Hearts, Inc. Actors Octavia Spencer and Sofía Vergara are part of the Detect the SOS Collective to raise awareness of uACR screening and increase testing Approximately 35 million U.S. adults are estimated to have chronic kidney disease, putting them at risk of cardiovascular events like heart attack or stroke; an important screening can help detect it early RIDGEFIELD, Conn. , Jan. 28, 2026 /PRNewswire/ -- Today, Boehringer Ingelheim and the Detect the SOS Collective, a group of professional organizations, advocates, patients and caregivers, launched a new public health mission: elevate awareness of urine albumin-to-creatinine ratio (uACR) screening to help uncover hidden risks for chronic kidney disease (CKD) and related cardiovascular (CV) events like heart attack or stroke. Experience the full interactive Multichannel News Release here: https://www.multivu.com/boehringer-ingelheim/9369051-en-boehringer-ingelheim-detect-the-sos-uacr-screening Continue Reading Boehringer Ingelheim convenes “Detect the SOS” Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks Speed Speed Photo Credit: Boehringer Ingelheim Photo Credit: Boehringer Ingelheim Photo Credit: Boehringer Ingelheim Photo Credit: Boehringer Ingelheim